Vytorin and Zetia
Vytorin is the combination of Zetia and Zocor, a statin now available as a generic drug for about one third of the cost.
A 2006 study completed by the makers of Zetia and Zocor indicate that these drugs are not effective for the treatment of heart attack and stroke.
PBM is investigating allegations that the companies misled consumers into believing that these drugs were more effective than Zocor in blocking the fatty arterial plaques that can cause heart attack and stroke.
A potential lawsuit would seek a refund of any monies spent by the purchasers of Vytorin and Zetia, which the study shows to be no more effective than the generic form of Zocor.
At Pogust Braslow & Millrood, we are accepting cases against the manufacturers of Vytorin and Zetia. That is why if you have purchased Vytorin or Zetia, you should immediately call the attorneys at Pogust Braslow & Millrood, where Protecting Consumers Is Our Primary Goal. We will evaluate your case, explain all of your options, and work to assure that the appropriate parties are held responsible. Just fill out this form, click here to send us an email or call us at (610) 941-4204.
|
